Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongkun Wang

Showing results (91-100 of 164) with videos related to

Pageof 17
Sort By:
Frontiers in Oncology|June 6, 2012
Survival outcomes of patients treated with hypofractionated stereotactic body radiation therapy for parotid gland tumors: a retrospective analysisSana D Karam, James W Snider, Hongkun Wang, et al.
Gastrointestinal Cancer Research : GCR|October 3, 2014
Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort studyBenjamin A Weinberg, Hongkun Wang, Xuezhong Yang, et al.
Stem Cell Research|October 11, 2020
Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parentJun Su, Jue Wang, Long Wang, et al.
Clinical and Translational Medicine|December 29, 2021
Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutationHangyuan Qiu, Yaxun Sun, Ziwei Pan, et al.
Journal of Pancreatic Cancer|July 10, 2020
A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to ChemotherapyBenjamin A Weinberg, Hongkun Wang, Agnieszka K Witkiewicz, et al.
Clinical Lung Cancer|November 4, 2025
Computer Assisted Nodule Analysis and Risk Yield Outcomes May be Associated with Recurrence after Stereotactic Body Radiation Therapy in Clinical Stage I Non-Small-Cell Lung CancerDuy Pham, Nikita Thakur, Ju Ae Park, et al.
NPJ Precision Oncology|July 8, 2025
A phase II single-arm study of combination pembrolizumab and olaparib in the treatment of patients with advanced biliary tract cancerNarayanan Sadagopan, Hongkun Wang, Chao Yin, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2015
Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinomaAndrew Gabrielson, Anteneh A Tesfaye, John L Marshall, et al.
JACC. Cardiovascular Imaging|April 10, 2009
Patterns of late gadolinium enhancement in chronic hemodialysis patientsBrian J Schietinger, Glenn M Brammer, Hongkun Wang, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 21, 2006
Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonanceDavid C Isbell, Craig H Meyer, Walter J Rogers, et al.
Pageof 17

Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|June 6, 2012
Survival outcomes of patients treated with hypofractionated stereotactic body radiation therapy for parotid gland tumors: a retrospective analysisSana D Karam, James W Snider, Hongkun Wang, et al.
Gastrointestinal Cancer Research : GCR|October 3, 2014
Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort studyBenjamin A Weinberg, Hongkun Wang, Xuezhong Yang, et al.
Stem Cell Research|October 11, 2020
Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parentJun Su, Jue Wang, Long Wang, et al.
Clinical and Translational Medicine|December 29, 2021
Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutationHangyuan Qiu, Yaxun Sun, Ziwei Pan, et al.
Journal of Pancreatic Cancer|July 10, 2020
A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to ChemotherapyBenjamin A Weinberg, Hongkun Wang, Agnieszka K Witkiewicz, et al.
Clinical Lung Cancer|November 4, 2025
Computer Assisted Nodule Analysis and Risk Yield Outcomes May be Associated with Recurrence after Stereotactic Body Radiation Therapy in Clinical Stage I Non-Small-Cell Lung CancerDuy Pham, Nikita Thakur, Ju Ae Park, et al.
NPJ Precision Oncology|July 8, 2025
A phase II single-arm study of combination pembrolizumab and olaparib in the treatment of patients with advanced biliary tract cancerNarayanan Sadagopan, Hongkun Wang, Chao Yin, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2015
Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinomaAndrew Gabrielson, Anteneh A Tesfaye, John L Marshall, et al.
JACC. Cardiovascular Imaging|April 10, 2009
Patterns of late gadolinium enhancement in chronic hemodialysis patientsBrian J Schietinger, Glenn M Brammer, Hongkun Wang, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 21, 2006
Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonanceDavid C Isbell, Craig H Meyer, Walter J Rogers, et al.
Pageof 17